MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 24.02.2026
Arvinas Kurzfristige Verbindlichkeiten 2011-2026 | ARVN
Kurzfristige Verbindlichkeiten Jährlich Arvinas
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 142 M | 230 M | 257 M | 295 M | 262 M | 49.1 M | 32.8 M | 23 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 295 M | 23 M | 161 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akebia Therapeutics
AKBA
|
163 M | $ 1.35 | -2.17 % | $ 347 M |  USA |
 |
Akari Therapeutics, Plc
AKTX
|
12.4 M | $ 3.5 | -21.7 % | $ 236 B |  Britain |
 |
Aldeyra Therapeutics
ALDX
|
27.8 M | $ 1.58 | -4.82 % | $ 94.9 M | USA |
 |
Aligos Therapeutics
ALGS
|
21.2 M | $ 8.36 | 4.89 % | $ 82.6 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
1.47 B | $ 330.71 | 3.72 % | $ 43.3 B | USA |
 |
Altimmune
ALT
|
15 M | $ 3.47 | 3.89 % | $ 306 M | USA |
 |
ALX Oncology Holdings
ALXO
|
24.6 M | $ 1.98 | 0.25 % | $ 106 M | USA |
 |
Amgen
AMGN
|
25.5 B | $ 346.45 | -0.43 % | $ 186 B | USA |
 |
I-Mab
IMAB
|
576 M | - | - | $ 866 M |  China |
 |
Amneal Pharmaceuticals
AMRX
|
882 M | $ 12.37 | -0.92 % | $ 3.88 B | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | USA |
 |
Anika Therapeutics
ANIK
|
31.1 M | $ 15.0 | 1.32 % | $ 220 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
194 M | $ 76.34 | 2.87 % | $ 1.47 B | USA |
 |
Annexon
ANNX
|
42.6 M | $ 5.64 | 2.45 % | $ 875 M | USA |
 |
Aptorum Group Limited
APM
|
4.34 M | $ 0.92 | -1.11 % | $ 5.02 M | China |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | USA |
 |
Aprea Therapeutics
APRE
|
2.76 M | $ 0.73 | 2.63 % | $ 4.77 M | USA |
 |
Aquestive Therapeutics
AQST
|
47.6 M | $ 4.15 | 0.48 % | $ 444 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
36.4 M | $ 8.43 | 4.98 % | $ 231 M |  Israel |
 |
Ardelyx
ARDX
|
88.6 M | $ 6.08 | 2.27 % | $ 1.47 B | USA |
 |
Acorda Therapeutics
ACOR
|
228 M | - | -24.86 % | $ 820 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
130 M | $ 23.93 | 1.27 % | $ 3.04 B | USA |
 |
Adverum Biotechnologies
ADVM
|
22.9 M | - | - | $ 86.2 M | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
195 M | $ 61.57 | 0.88 % | $ 8.24 B | USA |
 |
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | USA |
 |
Applied Molecular Transport
AMTI
|
15.1 M | - | - | $ 10.1 M | USA |
 |
Assembly Biosciences
ASMB
|
48.8 M | $ 30.01 | 3.43 % | $ 336 M | USA |
 |
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | USA |
 |
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | USA |
 |
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - |  Russia |
 |
Actinium Pharmaceuticals
ATNM
|
7.97 M | $ 1.14 | 16.28 % | $ 35.6 M | USA |
 |
Atossa Therapeutics
ATOS
|
8.26 M | $ 5.21 | -2.89 % | $ 44.9 M | USA |
 |
Atara Biotherapeutics
ATRA
|
14.9 M | $ 5.03 | 0.7 % | $ 63.1 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
15.7 M | - | 3.16 % | $ 1.9 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
93.7 M | $ 16.04 | 2.75 % | $ 2.16 B |  Canada |
 |
Autolus Therapeutics plc
AUTL
|
73.4 M | $ 1.42 | 0.35 % | $ 378 M | Britain |
 |
Alpine Immune Sciences
ALPN
|
58 M | - | - | $ 2.17 B | USA |
 |
Aileron Therapeutics
ALRN
|
6.18 M | - | 10.36 % | $ 9.8 M | USA |